187 related articles for article (PubMed ID: 27213814)
1. VNAR single-domain antibodies specific for BAFF inhibit B cell development by molecular mimicry.
Häsler J; Flajnik MF; Williams G; Walsh FS; Rutkowski JL
Mol Immunol; 2016 Jul; 75():28-37. PubMed ID: 27213814
[TBL] [Abstract][Full Text] [Related]
2. Isolation of highly selective IgNAR variable single-domains against a human therapeutic Fc scaffold and their application as tailor-made bioprocessing reagents.
Buschhaus MJ; Becker S; Porter AJ; Barelle CJ
Protein Eng Des Sel; 2019 Dec; 32(9):385-399. PubMed ID: 32119084
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
4. A novel VHH antibody targeting the B cell-activating factor for B-cell lymphoma.
Wu W; Li S; Zhang W; Sun J; Ren G; Dong Q
Int J Mol Sci; 2014 May; 15(6):9481-96. PubMed ID: 24879522
[TBL] [Abstract][Full Text] [Related]
5. Study on the Mechanism of Selective Interaction of BR3 and BCMA with BAFF and APRIL.
Li L; Jiang Y; Su L; Feng D; Wei J; Sun J
Protein Pept Lett; 2020; 27(11):1114-1123. PubMed ID: 32282294
[TBL] [Abstract][Full Text] [Related]
6. Antibodies That Block or Activate Mouse B Cell Activating Factor of the Tumor Necrosis Factor (TNF) Family (BAFF), Respectively, Induce B Cell Depletion or B Cell Hyperplasia.
Kowalczyk-Quintas C; Schuepbach-Mallepell S; Vigolo M; Willen L; Tardivel A; Smulski CR; Zheng TS; Gommerman J; Hess H; Gottenberg JE; Mackay F; Donzé O; Schneider P
J Biol Chem; 2016 Sep; 291(38):19826-34. PubMed ID: 27451394
[TBL] [Abstract][Full Text] [Related]
7. Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells.
Lee CV; Hymowitz SG; Wallweber HJ; Gordon NC; Billeci KL; Tsai SP; Compaan DM; Yin J; Gong Q; Kelley RF; DeForge LE; Martin F; Starovasnik MA; Fuh G
Blood; 2006 Nov; 108(9):3103-11. PubMed ID: 16840730
[TBL] [Abstract][Full Text] [Related]
8. Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease.
Benschop RJ; Chow CK; Tian Y; Nelson J; Barmettler B; Atwell S; Clawson D; Chai Q; Jones B; Fitchett J; Torgerson S; Ji Y; Bina H; Hu N; Ghanem M; Manetta J; Wroblewski VJ; Lu J; Allan BW
MAbs; 2019; 11(6):1175-1190. PubMed ID: 31181988
[TBL] [Abstract][Full Text] [Related]
9. Signals from activation of B-cell receptor with anti-IgD can override the stimulatory effects of excess BAFF on mature B cells in vivo.
Nguyen TG; Morris JM
Immunol Lett; 2014 Sep; 161(1):157-64. PubMed ID: 24954638
[TBL] [Abstract][Full Text] [Related]
10. B Cell-Activating Factor Antagonism Attenuates the Growth of Experimental Abdominal Aortic Aneurysm.
Spinosa MD; Montgomery WG; Lempicki M; Srikakulapu P; Johnsrude MJ; McNamara CA; Upchurch GR; Ailawadi G; Leitinger N; Meher AK
Am J Pathol; 2021 Dec; 191(12):2231-2244. PubMed ID: 34509440
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing human anti-B-cell-activating factor of the TNF family (BAFF) scFv selected from phage antibody library.
Cao P; Xia Z; Song W; Zhang S
Immunol Lett; 2005 Oct; 101(1):87-94. PubMed ID: 15939481
[TBL] [Abstract][Full Text] [Related]
12. BAFF Inhibition Effectively Suppresses the Development of Anti-HLA.A2 Antibody in the Highly Sensitized Mouse Model.
Min JW; Shin YJ; Lee H; Kim BM; Park KH; Doh KC; Kim TM; Lim SW; Yang CW; Oh EJ; Chung BH
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467096
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
14. Role of B Cell-Activating Factor in Chronic Obstructive Pulmonary Disease.
Seys LJ; Verhamme FM; Schinwald A; Hammad H; Cunoosamy DM; Bantsimba-Malanda C; Sabirsh A; McCall E; Flavell L; Herbst R; Provoost S; Lambrecht BN; Joos GF; Brusselle GG; Bracke KR
Am J Respir Crit Care Med; 2015 Sep; 192(6):706-18. PubMed ID: 26266827
[TBL] [Abstract][Full Text] [Related]
15. A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses.
Huntington ND; Tomioka R; Clavarino C; Chow AM; Liñares D; Maña P; Rossjohn J; Cachero TG; Qian F; Kalled SL; Bernard CC; Reid HH
Int Immunol; 2006 Oct; 18(10):1473-85. PubMed ID: 16914508
[TBL] [Abstract][Full Text] [Related]
16. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
[TBL] [Abstract][Full Text] [Related]
17. Identification of Anti-TNFα VNAR Single Domain Antibodies from Whitespotted Bambooshark (
Zhao L; Chen M; Wang X; Kang S; Xue W; Li Z
Mar Drugs; 2022 Apr; 20(5):. PubMed ID: 35621957
[TBL] [Abstract][Full Text] [Related]
18. BAFF regulates follicular helper t cells and affects their accumulation and interferon-γ production in autoimmunity.
Coquery CM; Loo WM; Wade NS; Bederman AG; Tung KS; Lewis JE; Hess H; Erickson LD
Arthritis Rheumatol; 2015 Mar; 67(3):773-84. PubMed ID: 25385309
[TBL] [Abstract][Full Text] [Related]
19. Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic binders.
Könning D; Rhiel L; Empting M; Grzeschik J; Sellmann C; Schröter C; Zielonka S; Dickgießer S; Pirzer T; Yanakieva D; Becker S; Kolmar H
Sci Rep; 2017 Aug; 7(1):9676. PubMed ID: 28852148
[TBL] [Abstract][Full Text] [Related]
20. Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology.
Gilbert JA; Kalled SL; Moorhead J; Hess DM; Rennert P; Li Z; Khan MZ; Banga JP
Endocrinology; 2006 Oct; 147(10):4561-8. PubMed ID: 16794009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
